Linked Life Data

12949694

Source:http://linkedlifedata.com/resource/pubmed/id/12949694

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
2003-9-1
pubmed:abstractText
We studied the effects of ANAR containing antibodies to morphine in ultralow doses on immunological parameters in patients with opium abuse. Changes in blood content of immunocompetent CD3+, CD16+, and HLA-DR+ cells, lymphocytes carrying receptors for serotonin and dopamine, and humoral immune factors were evaluated. As differentiated from standard preparations, ANAR possessed immunomodulatory properties, increased the content of HLA-DR+ lymphocytes and immunoglobulins in the blood, and normalized the number of CD16+ cells.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
1573-8221
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
135 Suppl 7
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
189-91
pubmed:dateRevised
2009-9-15
pubmed:meshHeading
pubmed:year
2003
pubmed:articleTitle
Changes in immunological parameters in patients with opium abuse receiving ANAR therapy.
pubmed:affiliation
Laboratory of Clinical Psychoneuroimmunology, Department of Addictions, Institute of Mental Health, Tomsk Research Center, Siberian Division of the Russian Academy of Medical Sciences.
pubmed:publicationType
Journal Article